Loading...


*  Dual Specificity Phosphatase 1 Regulates Human Inducible Nitric Oxide Synthase Expression by p38 MAP Kinase
W. Wang, G. Zhou, M. C. T. Hu, Z. Yao, and T. H. Tan, "Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, ... J. Bain, L. Plater, M. Elliott et al., "The selectivity of protein kinase inhibitors: a further update," Biochemical Journal, ... T. Boutros, E. Chevet, and P. Metrakos, "Mitogen-Activated Protein (MAP) kinase/MAP kinase phosphatase regulation: roles in ... A. Cuenda and S. Rousseau, "p38 MAP-Kinases pathway regulation, function and role in human diseases," Biochimica et Biophysica ...
  https://www.hindawi.com/journals/mi/2011/127587/ref/
*  Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 | The EMBO Journal
... protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in ... the proteasome inhibitors MG132 or LLnL, or the cysteine proteinase inhibitor E‐64d, prior to activation with thapsigargin (Tg ... Groom LA, Sneddon AA, Alessi DR, Dowd S and Keyse SM (1996) Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1 ... MAP) kinases pathways. For example, GR‐mediated inhibition of c‐Jun N‐terminal kinase (JNK) activity, leading to inhibition of ...
  http://emboj.embopress.org/content/20/24/7108
*  The Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Inhibitor PD184352 (CI-1040) Selectively...
... p44 MAP kinase) relative to ERK2 (p42 MAP kinase).. Inhibition of ERK MAP Kinase Activation by MEK Inhibitors. To test the ... 1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 5: 810-816. ... MAP kinase, mitogen-activated protein kinase; MEK, MAP kinase kinase or ERK kinase; p90RSK, 90-kDa ribosomal S6 kinase; Q-RT- ... Ras stimulation of the Raf-MAP kinase kinase (MEK)-MAP kinase (ERK) pathway is often required for cell proliferation. ...
  http://jpet.aspetjournals.org/content/316/1/456.long
*  DNA Repair
Constitutive MAP-kinase activation suppresses germline apoptosis in NTH-1 DNA glycosylase deficient C. elegans Henok Kassahun ... Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells Lingfeng He , Huan Yang , ... ... Constitutive MAP-kinase activation suppresses germline apoptosis in NTH-1 DNA glycosylase deficient C. elegans Henok Kassahun ... Advertising - Careers - Feedback - Site map - Terms and Conditions - Privacy Policy Cookies are used by this site. To decline ...
  https://www.journals.elsevier.com/dna-repair
*  DETECTING PAX2 FOR THE DIAGNOSIS OF BREAST CANCER - Patent application
23B shows MEK kinase inhibitors and AICAR suppresses PAX2 protein expression; FIG. 23C shows MEK kinase inhibitors and Losartan ... suppresses phospho-STAT3 protein expression. [0043] FIG. 24 shows effect of Los and MEK kinase inhibitors on PAX2 activation in ... 23 shows effect of Los and MAP Kinase inhibitors on PAX2 expression in DU145 cells. FIG. 23A shows treatment of DU145 cells ... 25 uM of the MEK inhibitor U0126, 20 uM of the MEK/ERK inhibitor PD98059 or 250 μM of the AMP kinase inducer AICAR. [0195] ...
  http://www.patentsencyclopedia.com/app/20130023425
*  JCI - MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma
A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol. 2005;23(3):329-336.. View this article ... C-KIT inhibitor dasatinib suppresses cell proliferation and the activation of the MNK/eIF4E axis in KIT-mutant melanomas. (A) ... a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase ... Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development. Proc Natl Acad Sci U S ...
  https://www.jci.org/articles/view/91258
*  Regulation of p38 and inflammation by MAPK kinases - Gary Firestein
... kinases are serine/threonine kinases that mediate signal transduction and orchestrate cellular responses to environmental ... If successful, these studies will support development of novel MAP kinase kinase inhibitors for RA. ... instead of p38 in murine arthritis models preserves IL-10 production and prevents increased activation of other MAP kinases;2) ... determining if p38 blockade suppresses IL-10 and activates ERK/JNK in RA samples and whether this is prevented by targeting ...
  http://grantome.com/grant/NIH/R01-AI070555-08
*  SX 011 | P38 MAPK inhibitor | Buy SX 011 from Supplier AdooQ®
... p38β and JNK-2 inhibitor. Reported to display no significant activity at p38γ, p38δ, ERK-2 and JNK-1. ... SB 203580 is a specific inhibitor of p38α and p38β which suppresses downstream activation of MAPKAP kinase-2 and heat shock ... VX-702 is an orally bioavailable inhibitor of p38 MAP kinase that inhibits platelet agonist induced p38 activation (IC50= 4 to ... SD-06 is a p38 MAP kinase inhibitor; inhibits p38α with an IC50 value of 170 nM and inhibits LPS-stimulated TNF-release in rats ...
  http://www.adooq.com/sx-011.html
*  Role of MAPK Kinase 6 in Arthritis: Distinct Mechanism of Action in Inflammation and Cytokine Expression | The Journal of...
Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. ... Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled ... MKK6 deficiency suppresses inflammatory arthritis and joint destruction, suggesting it might be a therapeutic target for ... The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU- ...
  http://www.jimmunol.org/content/183/2/1360
*  Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and...
... was accompanied by activation of NF?B and of the MAP kinase ERK, and clenbuterol also induced expression of the IL-1?-inducible ... Treatment with the noradrenaline reuptake inhibitor reboxetine combined with the ?2-adrenoceptor antagonist idazoxan induced ... clenbuterol suppresses the innate inflammatory response in rat brain. ... Here we examined the ability of pharmacological enhancement of central noradrenergic tone to impact upon activation of the IL-1 ...
  http://www.tara.tcd.ie/xmlui/handle/2262/38868
*  TRC 051384 | HSP70 inducer | Buy TRC 051384 from Supplier AdooQ®
1]. Induction of HSP70 is a natural response of stressed cells that protects neuronal cells from a variety of insults including ... belonging to substituted 2-propen-1-one class, is a potent inducer of heat shock protein 70 (HSP70) [ ... SB 203580 is a specific inhibitor of p38α and p38β which suppresses downstream activation of MAPKAP kinase-2 and heat shock ... VX-702 is an orally bioavailable inhibitor of p38 MAP kinase that inhibits platelet agonist induced p38 activation (IC50= 4 to ...
  http://www.adooq.com/trc-051384.html
*  Cited In for PubMed (Select 10330143) - PubMed - NCBI
Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190. ... A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK ... Systematic discovery of linear binding motifs targeting an ancient protein interaction surface on MAP kinases. ... Dynamic single cell measurements of kinase activity by synthetic kinase activity relocation sensors. ...
  https://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed_citedin&from_uid=10330143
*  Therapeutic Implications of PPAR in Cardiovascular Diseases
... publishes original research and review articles on advances in basic research focusing on mechanisms involved in the activation ... knockout mice through activation of p38 MAP kinase independent of PPAR. . Ding et al. reported that cardiomyocyte-specific PPAR ... Activation of PPAR. suppresses production of inflammatory cytokines, and there is accumulating data that PPAR. ligands exert ... associates with the protein inhibitor of activated STAT1 (PIAS1), which is a small ubiquitin-like modifier (SUMO)-E3 ligase, in ...
  https://www.hindawi.com/journals/ppar/2010/876049/
*  Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis | Signal Transduction...
... showed that AT2R activation decreases ERK1/2 activity via activation of phosphatases, such as MAP kinase phosphatase-1 (MKP-1). ... For examples, TNFα suppresses UCP1 expression in white adipocytes via extracellular signal-related kinase (ERK) activation11 ... by either chemical inhibitor or knockdown of ERK) is accompanied by improved AMPK and Akt signaling.40,42,43 Hence, one may ... Inflammation induced by RAW macrophages suppresses UCP1 mRNA induction via ERK activation in 10T1/2 adipocytes. . Am J Physiol ...
  https://www.nature.com/articles/sigtrans201722?error=cookies_not_supported&code=e9eb300c-2774-48c4-92a8-0f416b0c1191
*  Role of Akt Signaling in Mitochondrial Survival Pathway Triggered by Hypoxic Preconditioning | Circulation
PC leads to the activation of multiple kinases, including protein kinase C (PKC), MAP kinases, and tyrosine kinases.7 ... This protective effect was inhibited by treating the cells with LY294002 (50 μmol/L), a PI3 kinase inhibitor, for 10 minutes ... 9 Although the mechanism by which PC suppresses apoptosis pathways remains controversial,10 mitochondria appear to play a ... Ischemic preconditioning triggers the activation of MAP kinase and MAPKAP kinase 2 in rat heart. FEBS Lett. 1996; 396: 233-237. ...
  http://circ.ahajournals.org/content/109/24/3042
*  Protocols and Video Articles Authored by Stefan Bittner (Translated to Hindi)
... whereas TREK1 activation had the opposite effect. We identified altered mitogen-activated protein (MAP) kinase signaling, actin ... a synthetic bisindolylmaleimide and inhibitor of protein kinase Cβ, which is clinically under investigation for the treatment ... Although LY-317615 dose-dependently suppresses T-cell proliferation and cytokine production independent of antigen specificity ... The TASK1 Channel Inhibitor A293 Shows Efficacy in a Mouse Model of Multiple Sclerosis Experimental Neurology. Dec, 2012 , ...
  https://www.jove.com/author/Stefan_Bittner?language=Hindi
*  Frontiers | Lactose Induces Phenotypic and Functional Changes of Neutrophils and Macrophages to Alleviate Acute Pancreatitis in...
... lactose was able to suppress caerulein-induced inflammatory signaling pathways and to suppress chemoattractant TNF-α and MCP-1 ... lactose was able to suppress caerulein-induced inflammatory signaling pathways and to suppress chemoattractant TNF-α and MCP-1 ... Acinar cell inflammation with activation of MAP kinases and the transcription factor NF-κB is a key pathological event in early ... An antagonist of galectin-3 mimicking lactose suppresses neutrophil recruitment and activation in the pancreas after AP ...
  https://www.frontiersin.org/articles/10.3389/fimmu.2018.00751/full
*  Brain Sciences | Free Full-Text | Ethanol Neurotoxicity in the Developing Cerebellum: Underlying Mechanisms and Implications |...
... insulin-like growth factor 1 (IGF-I), and basic fibroblast growth factor (bFGF). In combination, these ethanol effects disrupt ... The survival effects of 25 mM KCl follow BDNF-independent stimulation of MAP kinase, and activation of Cam kinase II and PI3- ... Preincubation with PKC inhibitor reduces the RhoE level and suppresses the ethanol-induced activation of IRAK, NF-κB, and the ... Binding of BDNF to its receptor, TrkB, activates the MAP kinase, phospholipase C-γ (PLC-γ) and PI3-kinase pathways, and ...
  http://mdpi.com/2076-3425/3/2/941/htm
*  ILK (integrin-linked kinase)
... integrin-linked kinase), Authors: Isabel Serrano, Paul McDonald, Shoukat Dedhar. Published in: Atlas Genet Cytogenet Oncol ... inactivation of ILK suppresses YAP activation and tumour growth in vivo (Serrano et al., 2013c). Expression of LIMD2 is ... Identification and characterization of a novel integrin-linked kinase inhibitor.. Lee SL, Hsu EC, Chou CC, Chuang HC, Bai LY, ... cell body costamere terminal bouton dendritic shaft protein complex positive regulation of MAP kinase activity protein kinase B ...
  http://atlasgeneticsoncology.org/Genes/GC_ILK.html
*  Are Soy Products Effective in DMD? - PLOS Currents Muscular Dystrophy
... inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP ... The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-alpha activation and ameliorates muscle function and ... These include anti-oxidants, and tyrosine kinase and protease inhibitory activity. There are also anecdotal reports of health ... purified Bowman-Birk protease inhibitor or a combination of isoflavones and Bowman-Birk inhibitor. Mice were tested for their ...
  http://currents.plos.org/md/article/md-18-0004r1-are-soy-products-effective-in-dmd/
*  The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth | springermedizin.de
The local balance between inducers and inhibitors of angiogenesis is critical ... Rousseau S: p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in ... Kobayashi M: MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J ... Cunningham BD: Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. ...
  https://www.springermedizin.de/the-isoflavone-metabolite-6-methoxyequol-inhibits-angiogenesis-a/9552114
*  MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment...
Map kinase kinase 4 (MKK4) suppresses metastasis in a preclinical prostate cancer model. We hypothesize that MKK4 will ... As this process is transient and dependent on MKK4 activation, extension of kinase activation and/or MKK4 pathway activation ... and 5 μL of chilled 6X kinase reaction buffer15 and 10 μM of p38 inhibitor SB03580 (Calbiochem). The kinase reactions were ... pharmacologic activation of the kinase, inhibition of potential inverse correlates of MKK4 activation and specific activation ...
  http://onlinelibrary.wiley.com/doi/10.1002/ijc.26005/full
*  PP2C | Springer for Research & Development
In response to environmental stress, Wis1 MAP kinase kinase (MAPKK) phosphorylates Thr-171 and Tyr-173 in the T-loop of Spc1 ... Extensive effort to develop Wip1-specific inhibitors has been made, which has delivered peptide and chemical inhibitors that ... resulting in phosphorylation and activation of SnRK2. Active SnRK2 then induces gene expression through activation of the ... Two PP2C isoforms in budding yeast, Ptc1 and Ptc3, were identified in a screen for genes whose overexpression suppresses the ...
  https://rd.springer.com/referenceworkentry/10.1007/978-3-319-67199-4_249
*  MAPK11 - Wikipedia
Enslen H, Raingeaud J, Davis RJ (1998). "Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP ... suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression". J. Immunol. 173 (6 ... "Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase". J. Biol. Chem. 279 (39): 40994- ... The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple ...
  https://en.wikipedia.org/wiki/MAPK11
*  Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells. - PubMed - NCBI
Western blot analysis showing degree of inhibition of the MAP kinase pathway on a panel of NSCLC cell lines using 1% DMSO (D), ... even though many patients with cancer are receiving therapeutic kinase inhibitors. Regulators of cell-surface HLA amounts were ... Activation of EGFR is demonstrated by western blot G. EGFR inhibition upregulated surface HLA-ABC more than MEKi, despite ... MAPK signaling suppresses antigen presentation machinery and MAPK inhibition broadly up-regulates antigen presentation ...
  https://www.ncbi.nlm.nih.gov/pubmed/27680026